IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 401 filers reported holding IONIS PHARMACEUTICALS INC in Q1 2019. The put-call ratio across all filers is 1.90 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $1,024,000 | -0.1% | 17,084 | -0.2% | 0.01% | -14.3% |
| Q3 2019 | $1,025,000 | -1.4% | 17,112 | +6.4% | 0.01% | -12.5% |
| Q2 2019 | $1,040,000 | -19.6% | 16,084 | +1.0% | 0.01% | -20.0% |
| Q1 2019 | $1,294,000 | +58.0% | 15,930 | +5.3% | 0.01% | +42.9% |
| Q4 2018 | $819,000 | -10.7% | 15,133 | -14.8% | 0.01% | -12.5% |
| Q3 2018 | $917,000 | +13.9% | 17,762 | -2.6% | 0.01% | 0.0% |
| Q2 2018 | $805,000 | 0.0% | 18,240 | 0.0% | 0.01% | 0.0% |
| Q1 2018 | $805,000 | -7.4% | 18,240 | +5.6% | 0.01% | 0.0% |
| Q4 2017 | $869,000 | -1.5% | 17,267 | -0.7% | 0.01% | -20.0% |
| Q3 2017 | $882,000 | -0.6% | 17,387 | -0.2% | 0.01% | 0.0% |
| Q2 2017 | $887,000 | +29.7% | 17,418 | +2.3% | 0.01% | +11.1% |
| Q1 2017 | $684,000 | -11.3% | 17,034 | +5.6% | 0.01% | -18.2% |
| Q4 2016 | $771,000 | +6.9% | 16,127 | -18.0% | 0.01% | 0.0% |
| Q3 2016 | $721,000 | +66.9% | 19,674 | +6.1% | 0.01% | +57.1% |
| Q2 2016 | $432,000 | -15.0% | 18,540 | +47.8% | 0.01% | -22.2% |
| Q1 2016 | $508,000 | -21.5% | 12,546 | +20.0% | 0.01% | -25.0% |
| Q4 2015 | $647,000 | – | 10,455 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tweedy, Browne Co LLC | 3,541,046 | $126,557 | 6.89% |
| M28 Capital Management LP | 126,300 | $4,513,962 | 5.10% |
| Bellevue Group AG | 9,511,900 | $339,955,306 | 4.93% |
| Deep Track Capital, LP | 2,834,069 | $101,289,626 | 4.16% |
| BVF INC/IL | 2,560,761 | $91,521,598 | 3.35% |
| Sicart Associates LLC | 210,698 | $7,530,347 | 2.93% |
| Privium Fund Management B.V. | 182,773 | $6,532,307 | 2.19% |
| Camber Capital Management LP | 1,925,000 | $68,800 | 2.12% |
| Orbimed Advisors | 2,124,500 | $75,929,630 | 1.49% |
| SECTOR GAMMA AS | 146,441 | $5,233,801 | 1.27% |